- Antineoplastic Agent
- 3.5 mg
- Powder for injection
- white to off-white
Please view the product monograph to find details of all ingredients contained in this product. For additional generic & OTC product inquiries, please call 1-800-268-4127, option 3 or email firstname.lastname@example.org.
Store between 15°C - 30°C. Retain in original package to protect from light. Single-use vials. Discard unused portion. The product may be stored for up to eight hours in a syringe; however, total storage time for the reconstituted material must not exceed eight hours when exposed to normal indoor lighting.
ACT Bortezomib is a cytotoxic agent. Caution should be used during handling and preparation. Proper aseptic technique should be used since no preservative is present. Use of gloves and other protective clothing to prevent skin contact is recommended.
All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.
Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.
"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves